FDA recommends that updated Covid shots target omicron subvariant XBB.1.5 this fall
June 16, 2023 at 14:22 PM EDT
The FDA's decision is a win for vaccine makers Pfizer, Moderna and Novavax, which have all been developing versions of their Covid shots to target XBB.1.5.